The HepG2 (human liver cancer cells) viability was reduced, caspase-3 (CASP3) activity was increased, compared to the group treated with an irrelevant sequence, the interference of lncRNA-NEAT1 using siRNA led to upregulation of Bax protein expression and downregulation of Bcl-2 expression. Here, CASP3 is linked to liver cancer.